CodeMap® Briefing: 03/24/2025

Editor's Welcome: Today our friends from Laboratory Economics discuss which Medicare B Tests have grown and what tests have declined since 2023. Medicare Part B spending on clinical lab fee schedule (CLFS) tests fell by 5% overall. Payments declined significantly due to lower Covid-19 testing. Genetic testing and routine chemistry remain in demand. As always, please send us your comments, suggestions, and questions via email.

OIG Report Shows 5% Drop in CLFS Spending Medicare Part B spending on clinical lab fee schedule (CLFS) tests, including payments to independent lab.... Sorry, access to this content requires a current subscription. Click here for publications catalog. CPT copyright 2024 American Medical Association. All rights reserved. * The responsibility for the content of any "National Correct Coding Policy" included in this product is with the Centers for Medicare and Medicaid Services and no endorsement by the AMA is intended or should be implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, nonuse, or interpretation of information contained in this product.